Unjha Formulations Ltd.
Snapshot View

10.48 -0.54 ▼-4.9%

02 December 2022, 04:01:00 PM
Volume: 5,605

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.unjhaformulations.com
Market Cap 4.70 Cr.
Enterprise Value(EV) 2.65 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 1.23 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 8.51 Trailing Twelve Months Ending 2022-09
Industry PE 35.40 Trailing Twelve Months Ending 2022-09
Book Value / Share 6.17 Trailing Twelve Months Ending 2022-09
Price to Book Value 1.70 Calculated using Price: 10.48
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.45 Cr. 4,480,500 Shares
FaceValue 10
Company Profile
Unjha Formulations (U-For), incorporated in 1987, is the sister concern of Urvesh Psyllium Industries Limited. U-For is the pharmaceuticals manufacturing unit, which is going to various category of formulation like tablet, capsule, oral liquids, injectables (SVP) and powder section to manufacture ayurvedic as well as allopathy products.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-4.90%
1 Week
+2.04%
1 Month
+13.30%
3 Month
+10.43%
6 Month
-0.19%
1 Year
+5.86%
2 Year
+34.36%
5 Year
-20.0%
10 Year
+198.58%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 244.18 89.75 52.48 31.18 24.22 18.57 5.55 12.35
Return on Capital Employed (%) 68.66 73.70 67.61 32.15 25.41 25.57 26.80 21.13
Return on Assets (%) 3.84 4.92 8.26 8.82 6.79 7.89 8.37 2.86 7.23

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 0 0 1 1 1 2 2 2 2 3
Non Curr. Liab. 0
Curr. Liab. 4 3 2 3 3 2 2 2 1 2
Minority Int.
Equity & Liab. 4 3 3 4 4 4 4 4 3 4
Non Curr. Assets 1 1 1 1 1 1 1 1 1 1
Curr. Assets 2 2 2 2 3 3 3 2 2 3
Misc. Exp. not W/O 0 0 0 0 0
Total Assets 4 3 3 4 4 4 4 4 3 4

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 7 9 10 12 11 11 11 10 14 15
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 7 9 10 12 11 12 11 10 14 15
Total Expenditure -6 -9 -10 -12 -11 -11 -10 -10 -14 -15
PBIDT 0 0 0 0 0 0 1 1 1 1
Interest 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 0 0
Exceptional Items
PAT 0 0 0 0 0 0 0 0 0 1
Adjusted EPS 0 0 1 1 1 1 1 0 1 1

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 1 -1 0 0 0 0 0 -1 0
Cash Fr. Inv. 0 0 0 0 0 0 0 0 0 0
Cash Fr. Finan. 0 0 0 0 0 0 0
Net Change 0 0 0 0 0 0 0 0 -1 0
Cash & Cash Eqvt 0 1 0 0 0 0 1 1 0 0

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 36.92 36.92 36.92 36.92 36.92 36.92 36.92 36.92 36.92
Public 63.08 63.08 63.08 63.08 63.08 63.08 63.08 63.08 63.08
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Tue, 15 Nov 2022
Sub: Structural Digital Database (SDD) Compliance Certificate Under SEBI (PIT) Regulations For The Quarter Ended 30/09/2022
531762
Fri, 11 Nov 2022
Publish Un-Audited Financial Results For The Quarter And Half Year Ended As On 30/09/2022
Ref: Regulation - Reg. 33 (3) of Securities And Exchange Board Of India (Listing Obligations and Disclosures Requirements) Regulations 2015
Thu, 10 Nov 2022
Board Meeting Outcome for Approval Of Un-Audited Financial Results Of The Company For Quarter Ended And Half Year Ended On 30Th September 2022 And Out Come Of Board Meeting Held On 10Th November 2022.
: Intimation of Board Meeting as per Regu. 33 of Securities And Exchange Board Of India (Listing Obligations and Disclosures Requirements) Regulations 2015 - SEBI(LODR)

Technical Scans View Details >>

Fri, 02 Dec 2022
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above
Opening at Low Opening at Low

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 249,530.84 1,040.00 -0.6%
Cipla Ltd. 89,936.23 1,114.35 -0.9%
Divi's Laboratories Ltd. 89,761.56 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. 75,098.21 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. 70,043.98 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. 54,931.39 1,623.05 -1.2%
Max Healthcare Institute Ltd. 43,491.25 448.10 -0.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.50 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-09 35.23 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-09 29.99 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 24.23 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 83.18 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 68.92 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-09 46.09 448.10 -0.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.68 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-09 4.13 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-09 7.40 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.63 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 11.67 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 9.02 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-09 6.29 448.10 -0.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 0.12 448.10 -0.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 448.10 -0.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 448.10 -0.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 3,931.46 448.10 -0.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 605.05 448.10 -0.9%

FAQ's On Unjha Formulations Ltd.

What is Unjha Formulations share price?

Can I buy Unjha Formulations shares now?

What is the Market Cap of Unjha Formulations?

What are the key metrics to analyse Unjha Formulations?

What is the 52 Week High and Low of Unjha Formulations?

What is the trend of Unjha Formulations share price?